Objective response rate and complete response rates were encouraging for both treatments

The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor

This sounds important—I’d better delay my jogYou may well want a sit down, especially if you’re tasked with […]

Despite the success of vaccinations against organisms such as Haemophilus influenza type B and Neisseria meningitidis,1 mortality and […]

Lexicographic anniversariesEvery year since 20161 I have been contributing articles to The BMJ documenting medical anniversaries. The 2016 […]

Equitable research partnerships are fundamental to global health. They are often defined as those in which, at all […]

In the Christmas issue of The BMJ in 2012 I published an article on the British Abolitionists, arguing […]

Erdafitinib boosted survival in patients with certain conditions including metastatic urothelial carcinoma

International data questions the assumption that chronic myeloid leukaemia is now a ‘solved’ disease

Updated Date: Thu, 01 Jun 2023 00:00:00 EDT